Dr Reddy's Laboratories has signed with Takeda to promote and distribute the Qdenga dengue vaccine in India, with availability expected in the first half of 2027 after regulatory and market authorisation processes. The development offers another potential prevention option as dengue remains a public health concern, while mosquito control measures continue to be important.